PEN:NYSE
Penumbra Inc
US$ ३१७.५५
arrow_downward
-०.१४%(-०.४५) 1D
US$ ३१७.५४
arrow_downward
-०.००% (-०.००७९)bedtimeAfter hours
Closed: अक्टोबर २, १६:००:०४ GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PEN...
Open
US$ ३१८.३७
High
US$ ३१८.३७
Low
US$ ३१६.७८
Mkt. cap
१२.५१ अरब
Avg. vol.
३.५२ लाख
Volume
२.४० लाख
P/E ratio
७७.९९
52-wk high
US$ ३६२.४१
52-wk low
US$ २२१.२६
EPS
US$ ४.०७
Beta
०.७०
Shares outstanding
३.९४ करोड
No. of employees
५ हजार
Open
US$ ३१८.३७
High
US$ ३१८.३७
Low
US$ ३१६.७८
Mkt. cap
१२.५१ अरब
Avg. vol.
३.५२ लाख
Volume
२.४० लाख
P/E ratio
७७.९९
52-wk high
US$ ३६२.४१
52-wk low
US$ २२१.२६
EPS
US$ ४.०७
Beta
०.७०
Shares outstanding
३.९४ करोड
No. of employees
५ हजार
News stories
From web sources and news partners
AD HOC NEWS
·
१ दिन पहिले
Boston Scientific keeps Penumbra deal on track as Penumbra stock costs EUR 284.00
Zacks
·
१ दिन पहिले
IART vs. PEN: Which Stock Is the Better Value Option?
Profile
Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.
In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by year-end. Wikipedia
About Penumbra Inc